Bioelectronics Corp (BIEL)

[srinsocal]

Trash Talk

BIEL has achieved 5 FDA Indications, indications that most medical device companies spend $30 million a piece for.

BIEL received all of those FDA Clearances for an Accumulated Deficit of $38.3 million, investor money well spent to gain regulatory approvals.

Full Body OTC Musculoskeletal Pain was the important one granted on 2/3/2020. The FDA reviewed 3 Clinical Studies and said that ActiPatch was a Safe and Effective pain reliever for use on every Muscle, Joint and Bone in the body.

Since the Full Body Clearance BIEL has Partnered with 3 large, established companies to Market their own versions of ActiPatch products.